Eisai
4523.T
#2506
Rank
C$10.41 B
Marketcap
C$36.90
Share price
1.92%
Change (1 day)
-4.37%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: C$0.74 Billion

According to Eisai's latest financial reports the company's current earnings are C$5.06 Billion. In 2023 the company made an earning of C$0.74 Billion, an increase over its 2022 earnings that were of -C$32.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023C$0.74 B-2404.04%
2022-C$32.27 Million-103.6%
2021C$0.89 B-39.81%
2020C$1.49 B7.44%
2019C$1.38 B17.22%
2018C$1.18 B86.16%
2017C$0.63 B-23.52%
2016C$0.83 B26.97%
2015C$0.65 B22.3%
2014C$0.53 B-46.07%
2013C$0.99 B-21.85%
2012C$1.27 B-20.59%
2011C$1.59 B-8.91%
2010C$1.75 B19.21%
2009C$1.47 B